Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan

Quality of Life Research

Volumn 24, Issue 10, 2015, Pages 2541-2548

  Yu, Sheng Tsung ^a   Chang, Hsing Yi ^a   Yao, Kai Ping ^b   Lin, Yu Hsuan ^c   Hurng, Baai Shyun ^c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Ministry of Health and Welfare   (Taiwan)

Author keywords

EQ 5D; NHIS; SF 36; Taiwan; Validity

Indexed keywords

ADULT; ARTICLE; CONCURRENT VALIDITY; CONTROLLED STUDY; CONVERGENT VALIDITY; DISCRIMINANT VALIDITY; EUROQOL FIVE DIMENSIONS QUESTIONNAIRE; FEMALE; HUMAN; HYPOTHESIS; JAPAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE ASSESSMENT; SHORT FORM 36; TAIWAN; UNITED KINGDOM; VISUAL ANALOG SCALE; YOUNG ADULT; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SUBSTANCE-RELATED DISORDERS;

ADULT; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; TAIWAN; YOUNG ADULT;

EID: 84941421760     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-015-0978-7     Document Type: Article

References (31)

1. Jia, H., & Lubetkin, E. I. (2005). The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf),27(2), 156–164.
2. Coons, S. J., Rao, S., Keininger, D. L., & Hays, R. D. (2000). A comparative review of generic quality-of-life instruments. Pharmacoeconomics,17(1), 13–35.
3. Ware, J. E., Snow, K. K., Kosinski, M., Gandek, B., & New England Medical Center Hospital Health Institute. (1993). SF-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Center.
4. Ware, J. E, Jr, & Gandek, B. (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology,51(11), 903–912.
5. Lu, J. F., Tseng, H. M., & Tsai, Y. J. (2003). Assessment of health-related quality of life in Taiwan (I): Development and psychometric testing of SF-36 Taiwan version. Taiwan Journal of Public Health,22(6), 501–511.
6. Tseng, H. M., Lu, J. F., & Tsai, Y. J. (2003). Assessment of health-related quality of life in Taiwan (II): Norming and validation of SF-36 Taiwan version. Taiwan Journal of Public Health,22(6), 512–518.
7. Glasziou, P., Alexander, J., Beller, E., Clarke, P., & Group, A. C. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes,5, 21. doi:10.1186/1477-7525-5-21.
8. Mahadeva, S., Wee, H. L., Goh, K. L., & Thumboo, J. (2009). The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia. BMC Gastroenterology,9, 20. doi:10.1186/1471-230X-9-20.
9. Schrag, A., Selai, C., Jahanshahi, M., & Quinn, N. P. (2000). The EQ-5D—A generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry,69(1), 67–73.
10. Wang, H. M., Beyer, M., Gensichen, J., & Gerlach, F. M. (2008). Health-related quality of life among general practice patients with differing chronic diseases in Germany: Cross sectional survey. BMC Public Health,8, 246. doi:10.1186/1471-2458-8-246.
11. Liou, H. H., Chiang, S. S., Wu, S. C., Yang, W. C., & Huang, T. P. (1994). Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Zhonghua Yi Xue Za Zhi (Taipei),53(5), 276–281.
12. Lang, H. C., Chuang, L., Shun, S. C., Hsieh, C. L., & Lan, C. F. (2010). Validation of EQ-5D in patients with cervical cancer in Taiwan. Supportive Care in Cancer,18(10), 1279–1286. doi:10.1007/s00520-009-0745-9.
13. Chang, T. J., Tarn, Y. H., Hsieh, C. L., Liou, W. S., Shaw, J. W., & Chiou, X. G. (2007). Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. Journal of the Formosan Medical Association,106(12), 1023–1031. doi:10.1016/S0929-6646(08)60078-9.
14. Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics,11(4), 341–353. doi:10.1002/hec.673.
15. Lee, H. Y., Hung, M. C., Hu, F. C., Chang, Y. Y., Hsieh, C. L., & Wang, J. D. (2013). Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan. Journal of the Formosan Medical Association,. doi:10.1016/j.jfma.2012.12.015.
16. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care,35(11), 1095–1108.
17. Szende, A., Oppe, M., Devlin, N. J., & EuroQol-Group. (2007). EQ-5D value sets: Inventory, comparative review and user guide: Inventory, comparative review and user guide. Berlin: Springer.
18. Kontodimopoulos, N., Pappa, E., Niakas, D., Yfantopoulos, J., Dimitrakaki, C., & Tountas, Y. (2008). Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health,11(7), 1162–1169. doi:10.1111/j.1524-4733.2008.00356.x.
19. Shafie, A. A., Hassali, M. A., & Liau, S. Y. (2011). A cross-sectional validation study of EQ-5D among the Malaysian adult population. Quality of Life Research,20(4), 593–600. doi:10.1007/s11136-010-9774-6.
20. Savoia, E., Fantini, M. P., Pandolfi, P. P., Dallolio, L., & Collina, N. (2006). Assessing the construct validity of the Italian version of the EQ-5D: Preliminary results from a cross-sectional study in North Italy. Health and Quality of Life Outcomes,4, 47. doi:10.1186/1477-7525-4-47.
21. Ware, J. E, Jr, Gandek, B., Kosinski, M., Aaronson, N. K., Apolone, G., Brazier, J., et al. (1998). The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology,51(11), 1167–1170.
22. Yu, S. T., Chang, H. Y., Lin, M. C., & Lin, Y. H. (2009). Agreement between self-reported and health insurance claims on utilization of health care: A population study. Journal of Clinical Epidemiology,62(12), 1316–1322. doi:10.1016/j.jclinepi.2009.01.016.
23. Myers, C., & Wilks, D. (1999). Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Quality of Life Research,8(1–2), 9–16.
24. Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research,2(3), 169–180.
25. Aburuz, S., Bulatova, N., Twalbeh, M., & Gazawi, M. (2009). The validity and reliability of the Arabic version of the EQ-5D: A study from Jordan. Annals of Saudi Medicine,29(4), 304–308.
26. Cleemput, I., Kesteloot, K., Moons, P., Vanrenterghem, Y., Van Hooff, J. P., Squifflet, J. P., et al. (2004). The construct and concurrent validity of the EQ-5D in a renal transplant population. Value Health,7(4), 499–509. doi:10.1111/j.1524-4733.2004.74013.x.
27. Badia Llach, X., Herdman, M., & Schiaffino, A. (1999). Determining correspondence between scores on the EQ-5D “thermometer” and a 5-point categorical rating scale. Medical Care,37(7), 671–677.
28. Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: rEsults from a United Kingdom national questionnaire survey. BMJ,316(7133), 736–741.
29. Luo, N., Chew, L. H., Fong, K. Y., Koh, D. R., Ng, S. C., Yoon, K. H., et al. (2003). Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Annals of the Academy of Medicine, Singapore,32(5), 685–690.
30. Lubetkin, E. I., Jia, H., & Gold, M. R. (2004). Construct validity of the EQ-5D in low-income Chinese American primary care patients. Quality of Life Research,13(8), 1459–1468.
31. Brazier, J., Connell, J., Papaioannou, D., Mukuria, C., Mulhern, B., Peasgood, T., et al. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment,18(34), 1–188. doi:10.3310/hta18340.